Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Criteo S.A. Director's Dealing 2023

Mar 8, 2023

32108_dirs_2023-03-08_7d686ea0-c758-4158-a6c5-75b407346ca1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Criteo S.A. (CRTO)
CIK: 0001576427
Period of Report: 2023-03-06

Reporting Person: Balla Nathalie (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-06 Ordinary Shares M 2600 $20.90 Acquired 20400 Direct
2023-03-06 Ordinary Shares S 2600 $32.674 Disposed 17800 Direct
2023-03-06 Ordinary Shares M 22400 $20.90 Acquired 40200 Direct
2023-03-06 Ordinary Shares S 22400 $32.355 Disposed 17800 Direct
2023-03-06 Ordinary Shares M 12177 $18.49 Acquired 29977 Direct
2023-03-06 Ordinary Shares S 12177 $32.355 Disposed 17800 Direct
2023-03-07 Ordinary Shares M 4846 $18.62 Acquired 22646 Direct
2023-03-07 Ordinary Shares S 4846 $32.025 Disposed 17800 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-03-06 Non-employee Warrant (right to buy) $20.9 M 2600 Disposed 2028-10-25 Ordinary Shares (2600.0) Direct
2023-03-06 Non-employee Warrant (right to buy) $20.9 M 22400 Disposed 2028-10-25 Ordinary Shares (22400.0) Direct
2023-03-06 Non-employee Warrant (right to buy) $18.49 M 12177 Disposed 2029-10-24 Ordinary Shares (12177.0) Direct
2023-03-07 Non-employee Warrant (right to buy) $18.62 M 4846 Disposed 2029-10-24 Ordinary Shares (4846.0) Direct

Footnotes

F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2: The exercise price of the non-employee warrant is 19.71 euros. The U.S. dollar equivalent of the exercise price is $20.90 using the exchange rate as of March 6, 2023 (1.00 = $0.9431).

F3: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

F4: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.51 to $32.77 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.00 to $ 32.845 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The exercise price of the non-employee warrant is 17.44 euros. The U.S. dollar equivalent of the exercise price is $18.49 using the exchange rate as of March 6, 2023 (1.00 = $ 0.9431).

F7: The exercise price of the non-employee warrant is 17.44 euros. The U.S. dollar equivalent of the exercise price is $18.62 using the exchange rate as of March 7, 2023 (1.00 = $ 0.9366).

F8: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.19 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F9: Warrant granted on October 25, 2018. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on October 25, 2028.

F10: Warrant granted on October 24, 2019. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on October 24, 2029.